Salient Capital Advisors’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
Other funds holding ABT
Salient Capital Advisors's ABT Position: Q3 2017 in Review
Salient Capital Advisors sold out of Abbott (ABT) in Q3 2017, closing a stake of 42,076 shares — an estimated $2.04M sold.
Salient Capital Advisors first reported a position in ABT in Q2 2013 and held it in 17 quarters. The position peaked at $4.46M in Q1 2014. 1,597 funds tracked by Wall St. Rank hold ABT as of Q3 2017.
- Salient Capital Advisors reported no remaining Abbott position as of Q3 2017 after selling out during the quarter.
- Salient Capital Advisors sold 42,076 Abbott shares in Q3 2017, an estimated $2.04M.
- Salient Capital Advisors first reported a position in Abbott in Q2 2013 and held it in 17 quarters.
- Salient Capital Advisors's Abbott position peaked at $4.46M in Q1 2014.
- 1,597 funds tracked by Wall St. Rank held Abbott as of Q3 2017.
Based on Salient Capital Advisors's 13F filing for Q3 2017, filed 6 Nov 2017.